drugset / Trial / NCT02681198
Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy Volunteers
Phase 1
Completed
24 enrolled
USWM, LLC (dba US WorldMeds)
National Institute on Drug Abuse (NIDA) · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the pharmacokinetics, safety and tolerability of lofexidine HCl in the presence of paroxetine in healthy adults.
Timeline
- Start
- 2016-01
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lofexidine | Small molecule | 0.4 mg | — |
| Subject | Paroxetine | Small molecule | 40 mg | Oral |
Indications
No indication recorded.